The Effects of Repetitive Transcranial Magnetic Stimulation on Anxiety in Patients With Moderate to Severe Traumatic Brain Injury: A Post-hoc Analysis of a Randomized Clinical Trial

Priscila Aparecida Rodrigues, Ana Luiza Zaninotto, Hayden M Ventresca, Iuri Santana Neville, Cintya Yukie Hayashi, Andre R Brunoni, Vinicius Monteiro de Paula Guirado, Manoel Jacobsen Teixeira, Wellingson Silva Paiva, Priscila Aparecida Rodrigues, Ana Luiza Zaninotto, Hayden M Ventresca, Iuri Santana Neville, Cintya Yukie Hayashi, Andre R Brunoni, Vinicius Monteiro de Paula Guirado, Manoel Jacobsen Teixeira, Wellingson Silva Paiva

Abstract

Background: Traumatic brain injury (TBI) is one of the leading causes of neuropsychiatric disorders in young adults. Repetitive Transcranial Magnetic Stimulation (rTMS) has been shown to improve psychiatric symptoms in other neurologic disorders, such as focal epilepsy, Parkinson's disease, and fibromyalgia. However, the efficacy of rTMS as a treatment for anxiety in persons with TBI has never been investigated. This exploratory post-hoc analyzes the effects of rTMS on anxiety, depression and executive function in participants with moderate to severe chronic TBI. Methods: Thirty-six participants with moderate to severe TBI and anxiety symptoms were randomly assigned to an active or sham rTMS condition in a 1:1 ratio. A 10-session protocol was used with 10-Hz rTMS stimulation over the left dorsolateral prefrontal cortex (DLPFC) for 20 min each session, a total of 2,000 pulses were applied at each daily session (40 stimuli/train, 50 trains). Anxiety symptoms; depression and executive function were analyzed at baseline, after the last rTMS session, and 90 days post intervention. Results: Twenty-seven participants completed the entire protocol and were included in the post-hoc analysis. Statistical analysis showed no interaction of group and time (p > 0.05) on anxiety scores. Both groups improved depressive and executive functions over time, without time and group interaction (p s < 0.05). No adverse effects were reported in either intervention group. Conclusion: rTMS did not improve anxiety symptoms following high frequency rTMS in persons with moderate to severe TBI. Clinical Trial Registration: www.ClinicalTrials.gov, identifier: NCT02167971.

Keywords: anxiety disorder; depression; executive function; neuropsychology; transcranial magnetic stimulation; traumatic brain injury.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2020 Rodrigues, Zaninotto, Ventresca, Neville, Hayashi, Brunoni, de Paula Guirado, Teixeira and Paiva.

Figures

Figure 1
Figure 1
Flow diagram. CONSORT STATEMENT.
Figure 2
Figure 2
Graph: STAI-State scores during the 3 timeponts (baseline (1), after the rTMS (2), 3 months follow-up (3)) for both sham and active group.
Figure 3
Figure 3
Graph: BDI II scores during the 3 timeponts (baseline (1), after the rTMS (2), 3 months follow-up (3)) for both sham and active group.
Figure 4
Figure 4
Graph: Executive function index during the 3 timeponts (baseline (1), after the rTMS (2), 3 months follow-up (3)) for both sham and active group.

References

    1. Ghajar J. Traumatic brain injury. Lancet. (2000) 356:923–9. 10.1016/S0140-6736(00)02689-1
    1. Cole TB. Global road safety crisis remedy sought. JAMA. (2004) 291:2531–2. 10.1001/jama.291.21.2531
    1. Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation. (2007) 22:341–53. 10.3233/NRE-2007-22502
    1. Center for Disease Control and Prevention (2019) Available online at: (accessed February 15, 2020).
    1. Ponsford JL, Downing MG, Olver J, Ponsford M, Acher R, Carty M, et al. . Longitudinal follow-up of patients with traumatic brain injury: outcome at two, five, and ten years post-injury. J Neurotrauma. (2014) 31:64–77. 10.1089/neu.2013.2997
    1. de Almeida CER, de Sousa JL, Dourado JC, Gontijo PAM, Dellaretti MA, Costa BS. Traumatic brain injury epidemiology in Brazil. World Neurosurg. (2016) 87:540–7. 10.1016/j.wneu.2015.10.020
    1. Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, et al. . Estimating the global incidence of traumatic brain injury. J Neurosurg. (2018) 130:1−18. 10.3171/2017.10.JNS17352
    1. Little DM, Kraus MF, Joseph J, Geary EK, Susmaras T, Zhou XJ, et al. . Thalamic integrity underlies executive dysfunction in traumatic brain injury. Neurology. (2010) 74:558–64. 10.1212/WNL.0b013e3181cff5d5
    1. Gennarelli TA, Thibault LE, Graham DI. Diffuse axonal injury: an important form of traumatic brain damage. Neuroscientist. (1998) 4:202–15. 10.1177/107385849800400316
    1. Adams JH, Graham DI, Gennarelli TA, Maxwell WL. Diffuse axonal injury in nonmissile head-injury. J Neurol Neurosurg Psychiatry. (1991) 54:481–3. 10.1136/jnnp.54.6.481
    1. Graham DI, Adams JH, Legan S, Gennarelli TA, Thibault L. The distribution, nature and time course of diffuse axonal injury. Neuropathol Appl Neurobiol. (1985) 11:319.
    1. Gentleman SM, Roberts GW, Gennarelli TA, Maxwell WL, Adams JH, Kerr S, et al. . Axonal injury - a universal consequence of fatal closed-head injury. Acta Neuropathol. (1995) 89:537–43. 10.1007/s004010050286
    1. Gennarelli TA, Graham DI, Thibault LE. The processes involved in traumatic axonal injury. In: Schlag G, Redl H, Traber D. editors. Shock, Sepsis, and Organ Failure. Berlin; Heidelberg: Springer; (1997). p. 185–96.
    1. Rimel RW, Giordani B, Barth JT, Jane JA. Moderate head injury: completing the clinical spectrum of brain trauma. Neurosurgery. (1982) 11:344–51. 10.1227/00006123-198209000-00002
    1. Meythaler JM, Peduzzi JD, Eleftheriou E, Novack TA. Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil. (2001) 82:1461–71. 10.1053/apmr.2001.25137
    1. Gould KR, Ponsford JL, Spitz G. Association between cognitive impairments and anxiety disorders following traumatic brain injury. J Clin Exp Neuropsychol. (2014) 36:1–14. 10.1080/13803395.2013.863832
    1. McCauley SR, Boake C, Levin HS, Contant CF, Song JX. Postconcussional disorder following mild to moderate traumatic brain injury: anxiety, depression, and social support as risk factors and comorbidities. J Clin Exp Neuropsychol. (2001) 23:792–808. 10.1076/jcen.23.6.792.1016
    1. Hart T, Fann JR, Chervoneva I, Juengst SB, Rosenthal JA, Krellman JW, et al. . Prevalence, risk factors, and correlates of anxiety at 1 year after moderate to severe traumatic brain injury. Arch Phys Med Rehabil. (2016) 97:701–7. 10.1016/j.apmr.2015.08.436
    1. Whelan-Goodinson R, Ponsford J, Johnston L, Grant F. Psychiatric disorders following traumatic brain injury: their nature and frequency. J Head Trauma Rehabil. (2009) 24:324–32. 10.1097/HTR.0b013e3181a712aa
    1. Draper K, Ponsford J, Schoenberger M. Psychosocial and emotional outcomes 10 years following traumatic drain injury. J Head Trauma Rehabil. (2007) 22:278–87. 10.1097/01.HTR.0000290972.63753.a7
    1. Sardinha DS, Vieira RCA, Paiva WS, de Oliveira DV, de Sousa RMC. Behavioral changes and associated factors after diffuse axonal injury. J Trauma Nurs. (2019) 26:328–39. 10.1097/JTN.0000000000000471
    1. Iosifescu DV, Nierenberg AA, Alpert JE, Papakostas GI, Perlis RH, Sonawalla S, et al. . Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatment. Psychosomatics. (2004) 45:419–25. 10.1176/appi.psy.45.5.419
    1. Tiller JW. Depression and anxiety. Med J Aust. (2013) 199(S6):S28–31. 10.5694/mja12.10628
    1. Saade YM, Nicol G, Lenze EJ, Miller JP, Yingling M, Wetherell JL, et al. . Comorbid anxiety in late-life depression: relationship with remission and suicidal ideation on venlafaxine treatment. Depress Anxiety. (2019) 36:1125–34. 10.1002/da.22964
    1. Choi KW, Kim YK, Jeon HJ. Comorbid anxiety and depression: clinical and conceptual consideration and transdiagnostic treatment. Adv Exp Med Biol. (2020) 1191:219–35. 10.1007/978-981-32-9705-0_14
    1. Osborn AJ, Mathias JL, Fairweather-Schmidt AK, Anstey KJ. Anxiety and comorbid depression following traumatic brain injury in a community-based sample of young, middle-aged and older adults. J Affect Disord. (2017) 213:214–21. 10.1016/j.jad.2016.09.045
    1. Rogers JM, Read CA. Psychiatric comorbidity following traumatic brain injury. Brain Injury. (2007) 21:1321–33. 10.1080/02699050701765700
    1. Chou A, Morganti JM, Rosi S. Frontal lobe contusion in mice chronically impairs prefrontal-dependent behavior. PLoS ONE. (2016) 11:e0151418. 10.1371/journal.pone.0151418
    1. Auday ES, Pérez-Edgar KE. Limbic and prefrontal neural volume modulate social anxiety in children at temperamental risk. Depress Anxiety. (2019) 36:690–700. 10.1002/da.22941
    1. Yassin W, Callahan BL, Ubukata S, Sugihara G, Murai T, Ueda K. Facial emotion recognition in patients with focal and diffuse axonal injury. Brain Inj. (2017) 31:624–30. 10.1080/02699052.2017.1285052
    1. Scholten AC, Haagsma JA, Cnossen MC, Olff M, van Beeck EF, Polinder S. Prevalence of and risk factors for anxiety and depressive disorders after traumatic brain injury: a systematic review. J Neurotrauma. (2016) 33:1969–94. 10.1089/neu.2015.4252
    1. Farinde A. An examination of co-occurring conditions and management of psychotropic medication use in soldiers with traumatic brain injury. J Trauma Nurs. (2014) 21:153–7. 10.1097/JTN.0000000000000058
    1. Kronberg G, Bridi M, Abel T, Bikson M, Parra LC. Direct current stimulation modulates ltp and ltd: activity dependence and dendritic effects. Brain Stimul. (2017) 10:51–8. 10.1016/j.brs.2016.10.001
    1. Ziemann U. Thirty years of transcranial magnetic stimulation: where do we stand? Exp Brain Res. (2017) 235:973–84. 10.1007/s00221-016-4865-4
    1. Fritsch B, Reis J, Martinowich K, Schambra HM, Ji Y, Cohen LG, et al. . Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron. (2010) 66:198–204. 10.1016/j.neuron.2010.03.035
    1. Nitsche MA, Koschack J, Pohlers H, Hullemann S, Paulus W, Happe S. Effects of frontal transcranial direct current stimulation on emotional state and processing in healthy humans. Front Psychiatry. (2012) 3:58. 10.3389/fpsyt.2012.00058
    1. George MS. New methods of minimally invasive brain modulation as therapies in psychiatry: TMS, MST, VNS and DBS. Zhonghua Yi Xue Za Zhi. (2002) 65:349–60.
    1. Boechat-Barros R, Brasil-Neto JP. Transcranial magnetic stimulation in depression: results of bi-weekly treatment. Braz J Psychiatry. (2004) 26:100–2. 10.1590/S1516-44462004000200006
    1. Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. (2003) 2:145–56. 10.1016/S1474-4422(03)00321-1
    1. Knoch D, Gianotti LR, Pascual-Leone A, Treyer V, Regard M, Hohmann M, et al. . Disruption of right prefrontal cortex by low-frequency repetitive transcranial magnetic stimulation induces risk-taking behavior. J Neurosci. (2006) 26:6469–72. 10.1523/JNEUROSCI.0804-06.2006
    1. Iannone A, Cruz AP, Brasil-Neto JP, Boechat-Barros R. Transcranial magnetic stimulation and transcranial direct current stimulation appear to be safe neuromodulatory techniques useful in the treatment of anxiety disorders and other neuropsychiatric disorders. Arq Neuropsiquiatr. (2016) 74:829–35. 10.1590/0004-282X20160115
    1. Sagliano L, Atripaldi D, De Vita D, D'Olimpio F, Trojano L. Non-invasive brain stimulation in generalized anxiety disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. (2019) 93:31–8. 10.1016/j.pnpbp.2019.03.002
    1. Dilkov D, Hawken ER, Kaludiev E, Milev R. Repetitive transcranial magnetic stimulation of the right dorsal lateral prefrontal cortex in the treatment of generalized anxiety disorder: a randomized, double-blind sham controlled clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. (2017) 78:61–5. 10.1016/j.pnpbp.2017.05.018
    1. Diefenbach GJ, Bragdon LB, Zertuche L, Hyatt CJ, Hallion LS, Tolin DF, et al. . Repetitive transcranial magnetic stimulation for generalised anxiety disorder: a pilot randomised, double-blind, sham-controlled trial. Br J Psychiatry. (2016) 209:222–8. 10.1192/bjp.bp.115.168203
    1. White D, Tavakoli S. Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder. Ann Clin Psychiatry. (2015) 27:192–6.
    1. Balconi M, Ferrari C. Left DLPFC rTMS stimulation reduced the anxiety bias effect or how to restore the positive memory processing in high-anxiety subjects. Psychiatry Res. (2013) 209:554–9. 10.1016/j.psychres.2013.03.032
    1. Vicario CM, Salehinejad MA, Felmingham K, Martino G, Nitsche MA. A systematic review on the therapeutic effectiveness of non-invasive brain stimulation for the treatment of anxiety disorders. Neurosci Biobehav Rev. (2019) 96:219–31. 10.1016/j.neubiorev.2018.12.012
    1. Brunoni AR, Teng CT, Correa C, Imamura M, Brasil-Neto JP, Boechat R, et al. . Neuromodulation approaches for the treatment of major depression Challenges and recommendations from a working group meeting. Arq Neuropsiquiatr. (2010) 68:433–51. 10.1590/S0004-282X2010000300021
    1. Garland JS, Jaskot EM, Taylor J, Buccellato K, Atwal N, Pasquina PF. 135 evolution of a study of bilateral prefrontal transcranial magnetic stimulation (TMS) to treat the symptoms of mild TBI (mTBI) PTSD. CNS Spectr. (2020) 25:285–6. 10.1017/S1092852920000516
    1. Pink AE, Williams C, Alderman N, Stoffels M. The use of repetitive transcranial magnetic stimulation (rTMS) following traumatic brain injury (TBI): a scoping review. Neuropsychol Rehabil. (2019) 1−27. 10.1080/09602011.2019.1706585
    1. Hoy KE, McQueen S, Elliot D, Herring SE, Maller JJ, Fitzgerald PB. A pilot investigation of repetitive transcranial magnetic stimulation for post-traumatic brain injury depression: safety, tolerability, and efficacy. J Neurotrauma. (2019) 36:2092–8. 10.1089/neu.2018.6097
    1. Durmaz O, Ebrinc S, Ates MA, Algul A. Evaluation of repetitive transcranial magnetic stimulation for treatment resistant major depression and the impact of anxiety symptoms on outcome. Psychiatry Clin Psychopharmacol. (2017) 27:14–8. 10.1080/24750573.2017.1293239
    1. Mantovani A, Aly M, Dagan Y, Allart A, Lisanby SH. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. J Affect Disord. (2013) 144:153–9. 10.1016/j.jad.2012.05.038
    1. Prasko J, Záleský R, Bares M, Horácek J, Kopecek M, Novák T, et al. . The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett. (2007) 28:33–8.
    1. Elbeh KAM, Elserogy YMB, Khalifa HE, Ahmed MA, Hafez MH, Khedr EM. Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorders: double blind randomized clinical trial. Psychiatry Res. (2016) 238:264–9. 10.1016/j.psychres.2016.02.031
    1. Watts BV, Landon B, Groft A, Young-Xu Y. A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder. Brain Stimul. (2012) 5:38–43. 10.1016/j.brs.2011.02.002
    1. Boggio PS, Rocha M, Oliveira MO, Fecteau S, Cohen RB, Campanhã C, et al. . Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. (2010) 71:992–9. 10.4088/JCP.08m04638blu
    1. Oznur T, Akarsu S, Celik C, Bolu A, Ozdemir B, Akcay BD, et al. . Is transcranial magnetic stimulation effective in treatment-resistant combat related posttraumatic stress disorder? Neurosciences. (2014) 19:29–32.
    1. Reyes-López J, Ricardo-Garcell J, Armas-Castañeda G, García-Anaya M, Arango-De Montis I, González-Olvera JJ, et al. . Clinical improvement in patients with borderline personality disorder after treatment with repetitive transcranial magnetic stimulation: preliminary results. Braz J Psychiatry. (2018) 40:97–104. 10.1590/1516-4446-2016-2112
    1. Tovar-Perdomo S, McGirr A, Van den Eynde F, Rodrigues Dos Santos N, Berlim MT. High frequency repetitive transcranial magnetic stimulation treatment for major depression: dissociated effects on psychopathology and neurocognition. J Affect Disord. (2017) 217:112–7. 10.1016/j.jad.2017.03.075
    1. Berlim MT, McGirr A, Beaulieu MM, Turecki G. High frequency repetitive transcranial magnetic stimulation as an augmenting strategy in severe treatment-resistant major depression: a prospective 4-week naturalistic trial. J Affect Disord. (2011) 130:312–7. 10.1016/j.jad.2010.10.011
    1. Rollnik JD, Huber TJ, Mogk H, Siggelkow S, Kropp S, Dengler R, et al. . High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport. (2000) 11:4013–5. 10.1097/00001756-200012180-00022
    1. Epstein CM, Evatt ML, Funk A, Girard-Siqueira L, Lupei N, Slaughter L, et al. . An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease. Clin Neurophysiol. (2007) 118:2189–94. 10.1016/j.clinph.2007.07.010
    1. Nielson DM, McKnight CA, Patel RN, Kalnin AJ, Mysiw WJ. Preliminary guidelines for safe and effective use of repetitive transcranial magnetic stimulation in moderate to severe traumatic brain injury. Arch Phys Med Rehabil. (2015) 96(4 Suppl.):S138–44. 10.1016/j.apmr.2014.09.010
    1. Li S Zaninotto AL Neville IS Paiva WS Nunn D Fregni F Clinical utility of brain stimulation modalities following traumatic brain injury: current evidence. Neuropsychiatr Dis Treat. (2015) 11:1573–86. 10.2147/NDT.S65816
    1. Neville IS Zaninotto AL Hayashi CY Rodrigues PA Galhardoni R Ciampi de Andrade D . Repetitive TMS does not improve cognition in patients with TBI: a randomized double-blind trial. Neurology. (2019) 93:e190–9. 10.1212/WNL.0000000000007748
    1. Feltrin FS, Zaninotto AL, Guirado VMP, Macruz F, Sakuno D, Dalaqua M, et al. Longitudinal changes in brain volumetry and cognitive functions after moderate and severe diffuse axonal injury. Brain Injury. (2018) 32:1208–17. 10.1080/02699052.2018.1494852
    1. Adams JH, Doyle D, Ford I, Gennarelli TA, Graham DI, McLellan DR. Diffuse axonal injury in head-injury - definition, diagnosis and grading. Histopathology. (1989) 15:49–59. 10.1111/j.1365-2559.1989.tb03040.x
    1. Fioravanti ACM, Santos LdF, Maissonette S, Cruz APdM, Landeira-Fernandez J. Evaluation of the factorial structure of the trait anxiety scale of the STAI. Aval. psicol. (2006) 5:217–24.
    1. Spielberger CD, Vagg PR, Barker LR, Donham GW, Westberry LG. The factor structure of the state-trait anxiety inventory. In: Stress and Anxiety. Spielberger GSC. editor. Washington, DC: Hemisphere; (1980). p. 95–109.
    1. Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, et al. . Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol. (1994) 91:79–92. 10.1016/0013-4694(94)90029-9
    1. Beam W, Borckardt JJ, Reeves ST, George MS. An efficient and accurate new method for locating the F3 position for prefrontal TMS applications. Brain Stimul. (2009) 2:50–4. 10.1016/j.brs.2008.09.006
    1. Rossi S, Hallett M, Rossini PM, Pascual-Leone A, Group SoTC. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. (2009) 120:2008–39. 10.1016/j.clinph.2009.08.016
    1. Teasdale G, Jennett B. Assessment of coma and impaired consciousness - practical scale. Lancet. (1974) 2:81–4. 10.1016/S0140-6736(74)91639-0
    1. Spielberg CD, Gorsuch RL, Luschene R. Test Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologist Press; (1970).
    1. Gorenstein C, Andrade L. Validation of a Portuguese version of the Beck depression inventory and the state-trait anxiety inventory in Brazilian subjects. Braz J Med Biol Res. (1996) 29:453–7.
    1. Beck AT, Steer RA, Brown G. BDI-II: Beck Depression Inventory Manual. 2 ed San Antonio, TX: Psychological Corporation; (1996).
    1. Spreen O, Strauss E. A Compendium of Neuropsychological Tests Administration Norms and Commentary. 2nd ed. New York, NY: Oxford University Press; (1998).
    1. Weschler D. Weschler Adult Intelligence Scale. San Antonio, TX: The Psychological Corporation; (1997).
    1. Cohen H, Kaplan Z, Kotler M, Kouperman I, Moisa R, Grisaru N. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry. (2004) 161:515–24. 10.1176/appi.ajp.161.3.515
    1. Pretalli JB, Nicolier M, Chopard G, Vandel P, Tio G, Monnin J, et al. . Resting motor threshold changes and clinical response to prefrontal repetitive transcranial magnetic stimulation in depressed patients. Psychiatry Clin Neurosci. (2012) 66:344–52. 10.1111/j.1440-1819.2012.02341.x
    1. Milad MR, Rauch SL, Pitman RK, Quirk GJ. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol. (2006) 73:61–71. 10.1016/j.biopsycho.2006.01.008
    1. Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research–past, present, and future. Biol Psychiatry. (2006) 60:376–82. 10.1016/j.biopsych.2006.06.004
    1. Meyer DL, Davies DR, Barr JL, Manzerra P, Forster GL. Mild traumatic brain injury in the rat alters neuronal number in the limbic system and increases conditioned fear and anxiety-like behaviors. Exp Neurol. (2012) 235:574–87. 10.1016/j.expneurol.2012.03.012
    1. Olivier JD, Vinkers CH, Olivier B. The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Front Pharmacol. (2013) 4:74. 10.3389/fphar.2013.00074
    1. Moore EL, Terryberry-Spohr L, Hope DA. Mild traumatic brain injury and anxiety sequelae: a review of the literature. Brain Injury. (2006) 20:117–32. 10.1080/02699050500443558
    1. Su E, Bell M. Diffuse axonal injury, In: Laskowitz D, Grant G. editors. Translational Research in Traumatic Brain Injury. Boca Raton, FL: CRC Press; (2016). p. 41–48.
    1. Kratz AL, Sander AM, Brickell TA, Lange RT, Carlozzi NE. Traumatic brain injury caregivers: a qualitative analysis of spouse and parent perspectives on quality of life. Neuropsychol Rehabil. (2017) 27:16–37. 10.1080/09602011.2015.1051056
    1. Hallam TM, Floyd CL, Folkerts MM, Lee LL, Gong QZ, Lyeth BG, et al. . Comparison of behavioral deficits and acute neuronal degeneration in rat lateral fluid percussion and weight-drop brain injury models. J Neurotrauma. (2004) 21:521–39. 10.1089/089771504774129865
    1. Palmer AM, Marion DW, Botscheller ML, Bowen DM, DeKosky ST. Increased transmitter amino acid concentration in human ventricular CSF after brain trauma. Neuroreport. (1994) 6:153–6. 10.1097/00001756-199412300-00039
    1. Demirtas-Tatlidede A, Vahabzadeh-Hagh AM, Bernabeu M, Tormos JM, Pascual-Leone A. Noninvasive brain stimulation in traumatic brain injury. J Head Trauma Rehabil. (2012) 27:274–92. 10.1097/HTR.0b013e318217df55
    1. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab. (2004) 24:133–50. 10.1097/01.WCB.0000111614.19196.04
    1. Katsura K, Kristián T, Siesjö BK. Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem Soc Trans. (1994) 22:991–6. 10.1042/bst0220991
    1. Baeken C, Wu GR, van Heeringen K. Placebo aiTBS attenuates suicidal ideation and frontopolar cortical perfusion in major depression. Transl Psychiatry. (2019) 9:38. 10.1038/s41398-019-0377-x
    1. Zis P, Shafique F, Hadjivassiliou M, Blackburn D, Venneri A, Iliodromiti S, et al. . Safety, tolerability, and nocebo phenomena during transcranial magnetic stimulation: a systematic review and meta-analysis of placebo-controlled clinical trials. Neuromodulation. (2020) 23:291–300. 10.1111/ner.12946
    1. Valkonen-Korhonen M, Leinola H, Kononen M, Niskanen E, Purhonen M, Pakarinen M, et al. . Bifrontal active and sham rTMS in treatment-resistant unipolar major depression. Nord J Psychiatry. (2018) 72:586–92. 10.1080/08039488.2018.1500640
    1. Granato A, Fantini J, Monti F, Furlanis G, Musho Ilbeh S, Semenic M, et al. . Dramatic placebo effect of high frequency repetitive TMS in treatment of chronic migraine and medication overuse headache. J Clin Neurosci. (2019) 60:96–100. 10.1016/j.jocn.2018.09.021
    1. Zafonte RD, Fregni F, Bergin MJG, Goldstein R, Boudreau N, Monge I, et al. . Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a phase II randomized controlled pilot study: implications for understanding the placebo effect. Brain Inj. (2020) 34:34–41. 10.1080/02699052.2019.1677941
    1. Colagiuri B, Schenk LA, Kessler MD, Dorsey SG, Colloca L. The placebo effect: from concepts to genes. Neuroscience. (2015) 307:171–90. 10.1016/j.neuroscience.2015.08.017
    1. Polich G, Iaccarino MA, Kaptchuk TJ, Morales-Quezada L, Zafonte R. Placebo effects in traumatic brain injury. J Neurotrauma. (2018) 35:1205–12. 10.1089/neu.2017.5506
    1. Liu Y, Chen Y, Liang X, Li D, Zheng Y, Zhang H, et al. . Altered resting-state functional connectivity of multiple networks and disrupted correlation with executive function in major depressive disorder. Front Neurol. (2020) 11:272. 10.3389/fneur.2020.00272
    1. Klojcnik M, Kavcic V, Bakracevic Vukman K. Relationship of depression with executive functions and visuospatial memory in elderly. Int J Aging Hum Dev. (2017) 85:490–503. 10.1177/0091415017712186
    1. Chalah MA, Ayache SS. Noninvasive brain stimulation and psychotherapy in anxiety and depressive disorders: a viewpoint. Brain Sci. (2019) 9:82 10.3390/brainsci9040082

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe